The Dictatorship
Trump administration touts lower prices for 15 Medicare drugs
NEW YORK (AP) — Pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs after months of negotiations, reductions that are expected to produce billions in savings for taxpayers and older adults, the Trump administration said.
But the net prices it unveiled for a 30-day supply of each drug are not what Medicare recipients will pay at their pharmacy counters, since those final amounts will depend on each individual’s plan and how much they spend on prescriptions in a given year.
Health Secretary Robert F. Kennedy Jr. touted the deals as part of the administration’s efforts to address affordability concerns among Americans. The Medicare drug negotiation program that made them possible is mandated by law and began under President Joe Biden’s administration.
“President Trump directed us to stop at nothing to lower health care costs for the American people,” Kennedy said in a statement Tuesday evening. “As we work to Make America Healthy Again, we will use every tool at our disposal to deliver affordable health care to seniors.”
The announcement marks the completion of a second round of negotiations under a 2022 law that allows Medicare to haggle over the price it pays on the most popular and expensive prescription drugs used by older Americans, bringing the total number of negotiated drug prices to 25. The new round of negotiated prices will go into effect in 2027. Reduced prices for the inaugural round of 10 drugs negotiated by the Biden administration last year will go into effect in January.
Price negotiations apply to drugs treating diabetes, asthma, cancers and more
The latest negotiated prices apply to some of the prescription medications on which Medicare spends the most money, including the massively popular GLP-1 weight-loss and diabetes drugs Ozempic, Rybelsus and Wegovy. Some of the other drugs involved in the negotiations include Trelegy Ellipta, which treats asthma; Otezla, a psoriatic arthritis drug; and various drugs that treat diabetes, irritable bowel syndrome and different forms of cancer.
Dr. Mehmet Oz, Centers for Medicare and Medicaid Services administrator, said the administration delivered “substantially better outcomes for taxpayers and seniors in the Medicare Part D program” than the previous year’s deals.
Under the first round of Medicare price negotiations, the Biden administration said the program would have saved about $6 billion on net covered prescription drug costs, or about 22%, if it had been in effect the previous year. The Trump administration said its latest round would have saved the government about $8.5 billion in net spending, or 36%, if it had been in effect last year.
It’s unclear exactly how much money the newly announced deals could save Medicare beneficiaries when they are buying prescription drugs at the pharmacy because those costs are determined by various individual factors.
A new rule that kicked off this year also caps out-of-pocket drug costs for Medicare beneficiaries at $2,000, giving some relief to older adults affected by high-cost prescriptions. The administration said estimated out-of-pocket savings for Medicare beneficiaries with drug plans is about $685 million.
Spencer Perlman, director of health care research at Veda Partners, said the Trump administration’s improved outcomes probably resulted from the mix of drugs being negotiated and lessons learned from the first year of negotiations.
Net drug prices are proprietary, he said, but “if we take the administration at their word, I think it demonstrates that they have secured meaningful price concessions for seniors, meaning the Medicare Drug Price Negotiation Program is working as intended.”
Medicare recipients can’t get GLP-1 drugs for obesity, but the administration is making changes
The GLP-1 weight-loss drugs that were part of the negotiations have been especially scrutinized for their high out-of-pocket costs. Yet it’s still unclear to what extent Medicare beneficiaries who want to use the drugs to treat obesity will be able to do so.
Medicare has long been prohibited from paying for weight-loss treatments, but a separate deal recently announced between the Trump administration and two pharmaceutical companies included plans for a pilot program that will expand coverage for the drugs to additional high-risk obese and overweight people.
The Trump administration this year has also negotiated several unrelated deals with drug companies to lower the cost of their products for the wider population.
Pharmaceutical companies, meanwhile, have sued over the Medicare drug negotiations enabled by the 2022 Inflation Reduction Act and remain opposed to them.
“Whether it is the IRA or MFN, government price setting for medicines is the wrong policy for America,” Alex Schriver, senior vice president of public affairs at the Pharmaceutical Research and Manufacturers of America, or PhRMA, said in a statement. “These flawed policies also threaten future medical innovation by siphoning $300 billion from biopharmaceutical research, undermining the American economy and our ability to compete globally.”
Next year, Medicare will negotiate prices for another round of 15 drugs, including physician-administered drugs for the first time.
International rage over FIFA’s close ties to President Donald Trump has reached a fever pitch after soccer’s governing body announced a plan to sell a significant stake to an investor group led by Joshua Kushner, the brother of Trump’s son-in-law.
The president and his family have all but turned the White House into their personal piggy bank. And FIFA — which has its own sordid history of corruption — seems to have made itself a party to Trump’s self-enrichment under Gianni Infantino’s leadership, such as by paying for space inside Trump Tower in New York. (The organization has defended the office rental as a World Cup outpost.)
Soccer is seen by many as a unifying game. But Trump’s incorporation of FIFA into his political dynasty is threatening that idea.
FIFA has announced plans to sell a large minority stake in a new company that will run its main events, including the World Cup and Club World Cup, as part of a plan to triple the amount of development money it dishes out to its 211 member associations.
Under the proposals — which are subject to approval by a majority of those national associations and FIFA’s 37-member council — a new entity called FIFA Forward Enterprises (FFE) will take over all commercial operations, while FIFA remains the game’s global governing body and retains a majority stake in FFE.
A press release from FIFA confirmed the plans and said Thrive Eternal, which was launched by Joshua Kushner, is expected to lead the investment group that would control FIFA Forward Enterprise. FIFA did not clarify why Thrive Eternal was selected, and Kushner was already dabbling in sports.
But Trump basically has already given son-in-law Jared Kushner carte blanche to dictate U.S. foreign policy in the Middle East while simultaneously hatching business plans in the region. (Jared Kushner has denied any conflicts of interest.)
Joshua Kushner reportedly has been a major donor to Democrats. But, predictably, the idea of another Kushner becoming financially entwined with the World Cup — the world’s most popular sporting event — and basically being dropped into a position of global significance isn’t going over well. Several other soccer governing bodies have expressed concerns, including Europe’s UEFA.
“This crosses a line that football’s governing institutions should never cross,” UEFA said in a statement about The Athletic’s report, adding: “The soul and governance of football are not assets to trade — especially with zero transparency as to who gains financially. None of us are the owners of football. It is not FIFA’s to sell.”
Democrats on the House Judiciary Committee also rebuked the plan, writing on X: “Apparently the fake Peace Prize and giant lease with Trump Tower weren’t enough — now Infantino performs a kickback hat trick by pursuing a multibillion-dollar deal with Jared Kushner’s brother to sell ownership stakes in the World Cup to private investors.”
FIFA, Donald Trump’s favorite corrupt racketeering enterprise in world sports, is now going directly into business with the Trump family!
Apparently the fake Peace Prize and giant lease with Trump Tower weren’t enough—now Infantino performs a kickback hat trick by pursuing a… https://t.co/knSZibuMea
— House Judiciary Dems (@HouseJudiciary) July 28, 2026
Rep. Jamie Raskin, D-Md., has already launched an investigation into the FIFA leader’s relationship with the Trump administration, while dozens of European lawmakers — citing concerns about “potential breaches of political neutrality” — have called for the FIFA Ethics Committee to investigate Infantino. This new proposal seems unlikely to assuage those concerns.
But what it does seem likely to do is fuel global anger toward the U.S. — the kind that has been growing since Trump retook office.
And when you consider that, it’s truly remarkable how the same MAGA movement whose members whined for years about politics mixing with sports is now in lockstep with a president who seems dead-set on casting his shadow over every sports event he can.
This post on X basically sums up the foul stench around FIFA’s latest proposal.
Sepp Blatter was Infantino’s predecessor as FIFA president and oversaw the organization amid some of its many scandals. When heof all people, is warning about how Trump and Infantino’s relationship is “deeply damaging” soccer, it’s a sign of how far FIFA has descended into the gutter.
Ja’han Jones is an MS NOW opinion blogger. He previously wrote The ReidOut Blog.
Today’s edition of quick hits.
* In the Middle East: “Jordan’s air defenses intercepted five missiles launched from Iran early Wednesday, the country’s military said, hours after the U.S. military said it had knocked down an Iranian missile barrage launched against American forces in the Middle East, shattering a brief pause in fighting.”
* At the Fed: “The Federal Reserve on Wednesday voted to hold its key interest rate steady but not without opposition from three officials who have expressed concern over inflation and wanted to hike. Despite increasing support among some officials for a rate increase, the Federal Open Market Committee voted 9-3 to leave the federal funds rate in a range between 3.5% and 3.75%.”
* All eyes on Cornyn: “Sen. John Cornyn, R-Texas, has yet to decide whether he will vote to confirm acting Attorney General Todd Blanche to permanently head the Department of Justice after saying Wednesday he was ‘not prepared’ to lend his support to President Donald Trump’s nominee.”
* This request is intended to repay the National Park Service, whose funds Team Trump unjustly raided: “The Trump administration is asking Congress for an additional $10 million to cover costs related to Freedom 250 events recently held on the National Mall, including a prayer event, a fair and a fireworks show.”
* Will the Carroll case ever end? “The Supreme Court already denied the first of Donald Trump’s two petitions against E. Jean Carroll. But the second petition, filed Tuesday, stands a better chance of gaining the high court’s interest because it raises presidential immunity and is backed by the Justice Department.”
* I’m eager to hear why a private citizen can’t delete the contents of his own phone: “It sounds like something James Bond would use: a gadget that self-destructs if it falls into the wrong hands. But it’s actually an open-source operating system that can be downloaded onto Android phones. Federal prosecutors in Atlanta are bringing an obstruction charge against a U.S. citizen who gave customs officers what is known as a duress passcode, which activated software that erased the contents of his phone.”
* My advice: Read real books written entirely by real people: “A few years into the A.I. era, there is sobering evidence that a significant and growing portion of the novels being sold are written with or by chatbots, and that readers are buying them. A new study conducted by computer scientists using A.I. detection software to analyze thousands of self-published novels on Amazon, found that a substantial number of those novels contained chatbot-generated prose.”
See you tomorrow.
Steve Benen is a producer for “The Rachel Maddow Show,” the editor of MaddowBlog and an MS NOW political contributor. He’s also the bestselling author of “Ministry of Truth: Democracy, Reality, and the Republicans’ War on the Recent Past.”
Survivors of Jeffrey Epstein’s abuse said Wednesday that acting Attorney General Todd Blanche was “very condescending” toward them in their meeting with him this month and told them to “get to the point.”
Ahead of the Senate Judiciary Committee vote on whether to move President Donald Trump’s nomination as attorney general to the full Senate for a vote, the survivors were on Capitol Hill urging Republican lawmakers to deny Blanche the position.
Survivor Dani Bensky told reporters that the meeting a couple of weeks ago with Blanche, who had declined to meet with them for months, was “very condescending” and that he would not answer their questions on why investigative leads and referrals in the case have not been followed.
“He actually said the words ‘Get to the point’ to us,” Benskey said. “We’re survivors who have been waiting to meet with him for nine months, eight months.”
Another survivor said Blanche told them he had not read the files.
Bensky, who was standing with other survivors outside the office of Sen. John Cornyn, R-Texas, voiced appreciation for the senator for his support of survivors. The said they had not met with Cornyn Wednesday but had spoken to Judiciary Committee staff members, and that the meeting was “productive” and the staff members “were very pleasant and very open.”
Cornyn said Wednesday that he is “not prepared to vote yes” on Blanche’s nomination. He also called off a meeting with Blanche, saying the nominee had failed to provide proof that President Donald Trump’s “anti-weaponization” fund is officially dead.
Survivors have been campaigning for GOP holdouts to vote against Blanche’s confirmation. Bensky said her group had run into Sen. Thom Tillis, R-N.C., in the elevator earlier and that he said he would like to meet with them. Tillis has also suggested that he might oppose Blanche’s confirmation.
Bensky said it would have “a massive chilling effect to all survivors across the U.S.” if Blanche’s nomination is moved out of committee and to the full Senate.
Asked for the survivors’ final message to the lawmakers, Bensky said: “It’s not political. Just do the right thing. Just be on the right side of history.”
Erum Salam is a breaking news reporter for MS NOW, with a focus on how global events and foreign policy shape U.S. politics. She previously was a breaking news reporter for The Guardian.
- Live updates: Fauci invokes Fifth at Senate COVID hearing; Blanche nomination at stand-still
- Obama offers his summer reading suggestions
- More now say AI does more harm than good: Survey
- Trump says he ‘respects’ Biden’s pardon of Fauci
- Iran’s surprise attack in Jordan blows up pause in fighting
- US launches strikes on Iran in retaliation for failed attack on American troops
- FIFA faces global anger over plan to give Kushner brother a financial stake
- Wednesday’s Mini-Report, 7.29.26
- Epstein survivors say meeting with Todd Blanche was ‘very condescending’
- Trump administration to dispense $600M for vaccines RFK Jr. held up
-
The Josh Fourrier Show2 years agoDOOMSDAY: Trump won, now what?
-
Politics1 year agoFormer ‘Squad’ members launching ‘Bowman and Bush’ YouTube show
-
The Dictatorship1 year agoLuigi Mangione acknowledges public support in first official statement since arrest
-
Uncategorized2 years ago
Bob Good to step down as Freedom Caucus chair this week
-
Politics1 year agoFormer Kentucky AG Daniel Cameron launches Senate bid
-
The Dictatorship1 year agoPete Hegseth’s tenure at the Pentagon goes from bad to worse
-
Politics1 year agoBlue Light News’s Editorial Director Ryan Hutchins speaks at Blue Light News’s 2025 Governors Summit
-
The Dictatorship11 months agoMike Johnson sums up the GOP’s arrogant position on military occupation with two words